Fluorescent dyes and related methods

US9702870B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9702870-B2
Application numberUS-201615203607-A
CountryUS
Kind codeB2
Filing dateJul 6, 2016
Priority dateAug 7, 2012
Publication dateJul 11, 2017
Grant dateJul 11, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Fluorescent dyes with affinity for nucleic acids and related methods are provided. Dielectric or semiconducting films including fluorescent dyes with affinity for nucleic acids and related methods are also provided. Coumarin-based surfactants conjugated to the fluorescent dyes with affinity for nucleic acids and related methods are provided.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of staining a cell, the method comprising: combining a compound and the cell comprising a nucleic acid molecule to form a complex including the compound and the nucleic acid molecule, thereby staining the cell; and detecting the complex including the compound and the nucleic acid molecule, wherein the compound has the genera formula (I): wherein each of R 1 and R 2 are independently selected from the group consisting of hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted acyl, substituted or unsubstituted alkoxy, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl, or wherein R 1 and R 2 are joined together to form a substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; each of R 3A , R 3B , R 3C , R 3D , R 3E , R 3F , R 4A , R 4B , R 4C , and R 4D are independently selected from the group consisting of hydrogen, a halide, —OH, —NH 2 , —CN, —SH, —NO 2 , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted acyl, substituted or unsubstituted alkoxy, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl; and salts and isomers thereof; or the general formula (II): wherein each of R 1 and R 2 are independently selected from the group consisting of hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted acyl, substituted or unsubstituted alkoxy, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl, or wherein R 1 and R 2 are joined together to form a substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; each of R 3A , R 3B , R 3C , R 3D , R 3E , R 3F , R 4A , R 4B , R 4C , and R 4D are independently selected from the group consisting of hydrogen, a halide, —OH, —NH 2 , —CN, —SH, —NO 2 , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted acyl, substituted or unsubstituted alkoxy, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl; R 5 is selected from the group consisting of a halide, —CN, —NO 2 , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted acyl, substituted or unsubstituted alkoxy, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl; and salts and isomers thereof. 2. The method of claim 1 , further comprising detecting the complex including the compound and the nucleic acid molecule. 3. The method of claim 1 , wherein the compound has the genera formula (I), wherein each of R 1 and R 2 are independently selected from the group consisting of hydrogen, substituted or unsubstituted methyl, ethyl, propyl, isopropyl, isobutyl, sec-butyl, tert-butyl, pentyl, isopentyl, hexyl, heptyl, octyl, nonyl, decyl, substituted butyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted acyl, substituted or unsubstituted alkoxy, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl, or wherein R 1 and R 2 are joined together to form a substituted or unsubstituted heterocycloalkyl or substituted or unsubstituted heteroaryl; each of R 3A , R 3B , R 3C , R 3D , R 3E and R 3F are independently selected from the group consisting of hydrogen, a halide, —OH, —NH 2 , —CN, —SH, —NO 2 , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted acyl, substituted or unsubstituted alkoxy, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl; R 4A , R 4D are hydrogen; each of R 4B and R 4C are independently hydrogen or —CN; and salts and isomers thereof; or the general formula (II): wherein each of R 1 and R 2 are independently selected from the group consisting of hydrogen, substituted or unsubstituted methyl, ethyl, propyl, isopropyl, isobutyl, sec-butyl, tert-butyl, pentyl, isopentyl, hexyl, heptyl, octyl, nonyl, decyl, substituted butyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted acyl, substituted or unsubstituted alkoxy, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl, or wherein R 1 and R 2 are joined together to form a substituted or unsubstituted heterocycloalkyl or substituted or unsubstituted heteroaryl; each of R 3A , R 3B , R 3C , R 3D , R 3E and R 3F are independently selected from the group consisting of hydrogen, a halide, —OH, —NH 2 , —CN, —SH, —NO 2 , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted acyl, substituted or unsubstituted alkoxy, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl; R 4A , R 4D are hydrogen; each of R 4B and R 4C are independently hydrogen or —CN; R 5 is selected from the group consisting of a halide, —CN, —NO 2 , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted acyl, substituted or unsubstituted alkoxy, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl; and salts and isomers thereof; provided that when R 4A , R 4B , R 4C and R 4D are hydrogen, R 1 and R 2 are not phenyl. 4. The method of claim 1 , wherein each of R 1 and R 2 are independently selected from substituted or unsubstituted methyl, ethyl, propyl, isopropyl, isobutyl, sec-butyl, tert-butyl, pentyl, isopentyl, hexyl, heptyl, octyl, nonyl, decyl, substituted butyl, unsubstituted acyl, substituted or unsubstituted alkoxy, unsubstituted heteroalkyl, unsubstituted cycloalkyl, unsubstituted heterocycloalkyl, unsubstituted aryl, substituted or unsubstituted aryl, and unsubstituted heteroaryl. 5. The method of claim 1 , wherein each of R 1 and R 2 are unsubstituted methyl, ethyl, propyl, isopropyl, isobutyl, sec-butyl, tert-butyl, pentyl, isopentyl, hexyl, heptyl, octyl, nonyl, decyl, substituted butyl, or wherein R 1 and R 2 are joined together to form a substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl. 6. The method of claim 1 , wherein R 5 is fluorinated alkyl, fluorinated heteroalkyl, fluorinated acyl, fluorinated alkoxy, fluorinated cycloalkyl, fluorinated heterocycloalkyl, fluorinated aryl, or fluorinated heteroaryl.

Assignees

Inventors

Classifications

  • with fluorescent label · CPC title

  • Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title

  • with hetero atoms directly attached to the ring nitrogen atom · CPC title

  • Stain compositions · CPC title

  • C09B57/00Primary

    Other synthetic dyes of known constitution · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9702870B2 cover?
Fluorescent dyes with affinity for nucleic acids and related methods are provided. Dielectric or semiconducting films including fluorescent dyes with affinity for nucleic acids and related methods are also provided. Coumarin-based surfactants conjugated to the fluorescent dyes with affinity for nucleic acids and related methods are provided.
Who is the assignee on this patent?
Univ Washington Through Its Center For Commercialization
What technology area does this patent fall under?
Primary CPC classification C09B57/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).